Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Royalty Pharma (RPRX) Benefits from Biotech Funding Gap with Rising Returns and Market Dominance

Latitude Investment Management, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The letter emphasizes a long-term, fundamentals-driven investment philosophy, arguing that while stock prices can be volatile in the short run, they ultimately follow underlying earnings growth—illustrated through the “dog and owner” analogy. The portfolio delivered strong results in 2025, with earnings growing over 15% and...